Keck School of Medicine of USC

Keck School of Medicine of USC

We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.

 

COVID-19 in RMD Patients: What Are the Risk Factors for Severe COVID-19 Outcomes? Are Patients With APL Antibodies at Higher Risk for Thrombotic Events?

670 views
November 24, 2020
2 Comments
Login to view comments. Click here to Login
USC Clinical Rheumatology Update